/Companies

AvoMD

500 Global

Brooklyn, US · Founded 2018 · 18 known investors

Find your way into AvoMD

1,308 people in our graph can introduce you to the AvoMD team.

Sign up to see every warm intro you have to AvoMD

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the AvoMD team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Avo is a clinical artificial intelligence platform designed to reduce clinician burnout and improve healthcare outcomes by helping doctors practice evidence-based medicine. The platform serves hospitals and medical practices by replacing traditional paper-based clinical guidelines with intelligent, easy-to-use software integrated into existing clinical workflows.

Founders & leadership

AvoMD was founded in 2018 by Joongheum Park, Yair Saperstein, and Laurence Coman.

JPJoongheum Park
Joongheum ParkFounder / Executive Chairman / CPODr. Joongheum Park is the founder, Executive Chairman, and CPO of Avo, a clinical AI platform that helps healthcare providers make evidence-based decisions and follow clinical pathways within their electronic health records. His background spans computer science, machine learning, and work as a data scientist.
YSYair Saperstein
Yair SapersteinFounder / CEODr. Yair Saperstein is the founder and CEO of Avo, a clinical AI platform that helps healthcare providers access evidence-based medicine and clinical pathways within their EHR. He is board certified in Internal Medicine and Clinical Informatics, holds a Master of Public Health, and previously founded and ran two education-focused non-profit organizations.
LCLaurence Coman
Laurence ComanFounder / COOFounder / COO at Avo

Board

ON
Omar NjieBoard director

Investors · 18

500 Globallisted by 500 GlobalPalo Alto · $150K

How we know: press coverage · open dataset · 500 Global portfolio 2026-08 · Not right? Tell us

Dunamureported

How we know: press coverage · Not right? Tell us

Also in the syndicate · 3

Epsilon HealthMirae Asset CapitalScrub Capital

Funding

SEC filings, press & company announcements

$18.1M disclosed across 2 of 6 rounds · 2020–2026

▶$8.1MraisedJun 2023 · 40 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Yair SapersteinExecutive Officer, Director
  • Joongheum ParkExecutive Officer, Director
  • Laurence ComanExecutive Officer
  • Omar NjieDirector
Offering amount
$8.1M
Amount sold
$8.1M
First sale
Dec 2022
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

Companies working in the same space as AvoMD.

Frequently asked questions

What does AvoMD do?
Avo is a clinical artificial intelligence platform designed to reduce clinician burnout and improve healthcare outcomes by helping doctors practice evidence-based medicine. The platform serves hospitals and medical practices by replacing traditional paper-based clinical guidelines with intelligent, easy-to-use software integrated into existing clinical workflows.
Who founded AvoMD?
AvoMD was founded by Joongheum Park, Yair Saperstein, Laurence Coman in 2018.
Who are AvoMD's investors?
AvoMD's investors include 500 Global, AlleyCorp, Dunamu & Partners, Epsilon Health Investors, Las Olas Venture Capital, MedMountain Ventures, Noro-Moseley Partners, World Trade Ventures (WTV) and 7 more.
How much funding has AvoMD raised?
AvoMD has disclosed $18.1M raised across 2 of its 6 known rounds.
Where is AvoMD headquartered?
AvoMD is headquartered in Brooklyn, US.